Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,920.3
-38.3 (-1.30%)

 

  • STI Straits Times Index
    2,920.3
    -38.3 (-1.30%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,580.6
    5.3 (0.34%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,550.8
    -746.8 (-2.55%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,505.2
    -68.2 (-1.91%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,197.4
    -437.8 (-1.53%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,979.4
    -129.8 (-2.12%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,038.3M
  • Value: 1,443.0M
  • Rise: 72
  • Fall: 319
  • Unch: 386

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.004-
Oceanus^0.054+0.002
Jiutian Chemical0.098-0.007
China Star Food0.047+0.003
MMP Resources^0.006-0.003
Sembcorp Marine0.152-0.005
MarcoPolo Marine0.018-0.004
Artivision Tech0.012-
P5 Capital0.036-0.003
ThaiBev0.820+0.020

World Indices

World Indices
Name Last Change
Nasdaq 13,270.6 -355.5
HSI 28,550.8 -746.8
HSCEI 11,334.0 -317.2
Jakarta 5,979.4 -129.8
Nikkei 225 28,197.4 -437.8
SSE Comp 3,505.2 -68.2
Shanghai A 3,674.1 -71.5
Shanghai B 245.7 -1.8
KOSPI 3,069.1 -53.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 28 Jan 2021 17:04
Last (SGD): 0.310 Change: -0.015 High: 0.325 Remarks: -
Change (%): -4.62 Low: 0.310
Open 0.325 Yesterday's Close 0.325
Buy Price 0.310 Sell Price 0.315
Buy Volume ('000) 518.2 Sell Volume ('000) 191.5
Cumulative Volume ('000) 1,415.6 Cumulative Value 448,381
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.01822 Trailing EPS (SGD) e -0.01197 NAV (SGD) b 0.0408
PE a - Trailing PE f - Price / NAV b 7.5980
Dividend (SGD) d - Cash In Hand (SGD) g 0.0329 Issued & Paid-up Shares c 264,047,000
Dividend Yield (%) d - Price / Cash In Hand g 9.422 Treasury Shares h -
Beta - 75 Daysi 0.333 R-Squared - 75 Days(%)i 1.03 Market Cap (M) 81.855
Beta - 500 Daysi 0.411 R-Squared - 500 Days (%)i 0.76 Enterprise Value (M) 76.750
Piotroski F Score 2 Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 78.0825 6-Month VWAP 0.351 Free Float (%) 34.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 01 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 81.855 - - 7.5980 -
Industry Medical & Biotechnology SGX 959.822 18.242 20.489 1.3616 2.080
Medical Specialties SGX 2,885.675 28.225 12.245 8.3352 1.817
Index FTSE ST Catalist Index SGX 57.108 30.063 88.683 1.3662 1.235
Local Peer Top Glove SGX 16,207.488 26.695 11.994 8.9026 1.932
Local Peer Medtecs Intl SGX 560.399 357.895 10.147 3.9673 -
Local Peer UGHealthcare SGX 431.381 32.184 32.188 6.0501 0.325
Local Peer Annica SGX 16.675 - - 5.0000 -
Local Peer Yunnan Energy SGX 16.251 - - 0.3360 -
Global Peer ABBOTT LABORATORIES NYSE 202,563.024 55.254 60.557 6.4539 1.149
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 191,223.711 51.738 39.193 6.0088 0.158
Global Peer DANAHER CORP NYSE 157,845.769 63.422 50.671 4.5497 0.300
Global Peer MEDTRONIC PLC NYSE 150,081.230 31.339 42.432 2.9918 2.002
Global Peer INTUITIVE SURGICAL INC NASDAQ 89,192.505 84.096 84.096 9.1394 -
Global Peer STRYKER CORP NYSE 86,713.773 41.629 49.381 6.6775 0.922
Global Peer BECTON DICKINSON & CO NYSE 72,971.858 95.139 95.139 3.0708 1.272
Global Peer EDWARDS LIFESCIENCES CORP NYSE 52,876.360 50.508 66.587 12.5588 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 51,447.163 38.020 38.020 3.5423 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 51,291.374 10.913 13.919 3.2955 -
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), AGILENT TECHNOLOGIES INC (NYSE), DEXCOM INC (NASDAQ), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), HOLOGIC INC (NASDAQ), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), INSULET CORPORATION (NASDAQ), WATERS CORP (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), NOVOCURE LTD (NASDAQ), PERKINELMER INC (NYSE), ABIOMED INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), MASIMO CORPORATION (NASDAQ), MICROPORT (HKEx), TOPGLOV (Bursa), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), HARTA (Bursa), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), QUIDEL CORP (NASDAQ), BRUKER CORPORATION (NASDAQ), WEIGAO GROUP (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), INARI MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), SUPERMX (Bursa), NANO-X IMAGING LTD (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), EBOS GROUP (ASX), CANTEL MEDICAL CORP (NYSE), CONMED CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), NUVASIVE INC (NASDAQ), LIFETECH SCI (HKEx), ATRICURE INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), PEIJIA-B (HKEx), AVANOS MEDICAL INC (NYSE), EARGO INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), INMODE LTD (NASDAQ), AK MEDICAL (HKEx), PULMONX CORPORATION (NASDAQ), KANGJI MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), NANOSONICS LIMITED (ASX), HESKA CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), 908 DEVICES INC (NASDAQ), ATRION CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CERUS CORP (NASDAQ), INOGEN INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), CIRC (HKEx), GENMARK DIAGNOSTICS INC (NASDAQ), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), CHUNLI MEDICAL (HKEx), SI BONE INC (NASDAQ), DERMTECH INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), CELLDEX THERAPEUTICS INC (NASDAQ), ZYNEX INC (NASDAQ), KDL MEDICAL (HKEx), ANTARES PHARMA INC (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), AXOGEN INC (NASDAQ), SURMODICS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), QUOTIENT LTD (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), PROFOUND MED CORP (NASDAQ), CORMEDIX INC (NYSE American), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACCURAY INCORPORATED (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CUTERA INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), YESTAR HEALTH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), INVACARE CORP (NYSE), APYX MEDICAL CORPORATION (NASDAQ), STEREOTAXIS INC (NYSE American), NEURONETICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), IRADIMED CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MISONIX INC (NASDAQ), AROA BIOSURGERY LTD (ASX), SOLITON INC (NASDAQ), ALPHA PRO TECH (NYSE American), TITAN MEDICAL INC (NASDAQ), SIENTRA INC (NASDAQ), CYCLOPHARM LIMITED (ASX), TELA BIO INC (NASDAQ), KELFRED (HKEx), REPRO MEDSYSTEMS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), INTRICOM CORP (NASDAQ), VINCENT MED (HKEx), ATOSSA THERAPEUTICS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SURGALIGN HOLDINGS INC (NASDAQ), PAVMED INC (NASDAQ), AVINGER INC (NASDAQ), ONCOCYTE CORP (NYSE American), ELECTROCORE INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), SOMNOMED LIMITED (ASX), VOLITIONRX LIMITED (NYSE American), FONAR CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BIOLASE INC (NASDAQ), IMPEDIMED LIMITED (ASX), APOLLO ENDOSURGERY INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), PW MEDTECH (HKEx), NEMAURA MEDICAL INC (NASDAQ), MICRO-X LTD (ASX), LKL (Bursa), DELCATH SYSTEMS INC (NASDAQ), CONFORMIS INC (NASDAQ), CELSION CORPORATION (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), RGTBHD (Bursa), ZOSANO PHARMA CORP (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), BIOMERICA INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), NEPHROS INC (NASDAQ), ELECTROMED INC (NYSE American), CHECK-CAP LTD (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), RESPIRI LTD (ASX), SDI LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), LENSAR INC (NASDAQ), RESONANCE HEALTH LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), IRIDEX CORP (NASDAQ), CARDIEX LTD (ASX), COMPUMEDICS (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), DAXOR CORP (NYSE American), OPTISCAN IMAGING (ASX), MOTUS GI HOLDINGS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), REWALK ROBOTICS LTD (NASDAQ), DIMERIX LTD (ASX), APPLIED UV INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), TRUSCREEN GROUP LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), NEOVASC INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LBT INNOVATIONS LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), METALICITY LIMITED (ASX), NANOVIBRONIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), USCOM LTD (ASX), DYNATRONICS CORP (NASDAQ), NEUROMETRIX INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ADHERIUM LIMITED (ASX), ANALYTICA (ASX), DORSAVI LTD (ASX), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.010
-3.12 %
10 Days --0.010
-3.12 %
20 Days -+0.010
+3.33 %
Medium Term Return 3 Months -+0.010
+3.33 %
6 Months --0.105
-25.30 %
1 Year -+0.075
+31.91 %
Long Term Return 2 Years -+0.080
+34.78 %
Annualised Return Annualised --
+16.10 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.175 - 0.885 Change From 1 Year Low +0.135 % Change From 1 Year Low (%) +77.14
Change From 1 Year High -0.575 % Change From 1 Year High (%) -64.97
2 Years Range 0.175 - 0.885 Change From 2 Years Low +0.135 % Change From 2 Years Low (%) +77.14
Change From 2 Years High -0.575 % Change From 2 Years High (%) -64.97
5 Years Range 0.175 - 0.885 Change From 5 Years Low +0.135 % Change From 5 Years Low (%) +77.14
Change From 5 Years High -0.575 % Change From 5 Years High (%) -64.97
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) +10.71 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.32 MB)
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
28 Jan 2021 0.325 0.325 0.310 0.310 1,415,600 0.3167
27 Jan 2021 0.335 0.335 0.325 0.325 952,900 0.3327
26 Jan 2021 0.345 0.350 0.330 0.330 6,607,400 0.3398
25 Jan 2021 0.315 0.325 0.310 0.315 1,040,100 0.3176
22 Jan 2021 0.320 0.325 0.315 0.315 691,200 0.3163
21 Jan 2021 0.330 0.330 0.315 0.320 794,500 0.3222
20 Jan 2021 0.325 0.330 0.320 0.325 2,413,500 0.3242
19 Jan 2021 0.315 0.325 0.315 0.320 2,061,500 0.3185
18 Jan 2021 0.315 0.320 0.310 0.320 732,200 0.3143
15 Jan 2021 0.320 0.325 0.310 0.315 886,500 0.3156
14 Jan 2021 0.325 0.330 0.315 0.320 1,861,300 0.3215
13 Jan 2021 0.315 0.330 0.315 0.325 4,179,100 0.3227
12 Jan 2021 0.310 0.315 0.305 0.310 1,001,100 0.3104
11 Jan 2021 0.320 0.325 0.310 0.310 1,653,400 0.3157
08 Jan 2021 0.305 0.325 0.305 0.315 6,253,700 0.3154
07 Jan 2021 0.300 0.305 0.295 0.300 1,105,000 0.2998
06 Jan 2021 0.300 0.305 0.295 0.300 618,800 0.2994
05 Jan 2021 0.300 0.310 0.295 0.300 4,147,900 0.3017
04 Jan 2021 0.295 0.305 0.295 0.300 716,600 0.2993
31 Dec 2020 0.295 0.300 0.295 0.300 40,700 0.2953
30 Dec 2020 0.295 0.305 0.295 0.300 565,900 0.2999
29 Dec 2020 0.295 0.300 0.290 0.295 488,300 0.2939
Summary
Current 2 Weeks
(15 Jan 2021 to 28 Jan 2021)
0.320 0.350 0.310 0.310 17,595,400 -
Previous 2 Weeks
(31 Dec 2020 to 14 Jan 2021)
0.295 0.350 0.295 0.320 21,577,600 -
4 Weeks from
(02 Dec 2020 to 30 Dec 2020)
0.350 0.350 0.310 0.300 30,312,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.